153 related articles for article (PubMed ID: 36628893)
21. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
22. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
[TBL] [Abstract][Full Text] [Related]
23. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
[TBL] [Abstract][Full Text] [Related]
24. Survival analysis of patients with extrahepatic cholangiocarcinoma: a nomogram for clinical and MRI features.
Zeng Y; Wang X; Wu J; Wang L; Shi F; Shu J
BMC Med Imaging; 2024 Jan; 24(1):7. PubMed ID: 38166729
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
[TBL] [Abstract][Full Text] [Related]
26. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Hou GM; Jiang C; Du JP; Yuan KF
Cancer Med; 2022 Jan; 11(2):317-331. PubMed ID: 34866356
[TBL] [Abstract][Full Text] [Related]
28. Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma.
Perez M; Hansen CP; Burdio F; Pellino G; Pisanu A; Salvia R; Di Martino M; Abu Hilal M; Aldrighetti L; Ielpo B;
J Am Coll Surg; 2022 Nov; 235(5):703-712. PubMed ID: 36102558
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.
Huang Y; Du Z; Kan A; He M; Li H; Lai Z; Wen D; Huang L; Li Q; Xu L; Shi M
Front Immunol; 2024; 15():1260191. PubMed ID: 38384459
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
[No Abstract] [Full Text] [Related]
31. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
[TBL] [Abstract][Full Text] [Related]
32. SUOX and GLUT1 are biomarkers for the prognosis in large duct type intrahepatic cholangiocarcinoma.
Kinjo Y; Naito Y; Akiba J; Sadashima E; Nakayama M; Tanigawa M; Hisaka T; Okabe Y; Yano H
Hum Pathol; 2022 Oct; 128():11-19. PubMed ID: 35764144
[TBL] [Abstract][Full Text] [Related]
33. A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
Yeh CN; Wang SY; Chen YY; Chen MH; Chiang KC; Cheng CT; Tsai CY; Wang CC; Yeh TS; Chen TC
Anticancer Res; 2016 Aug; 36(8):4249-58. PubMed ID: 27466540
[TBL] [Abstract][Full Text] [Related]
34. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.
Guo K; Lou Y; Zheng S
Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Rimini M; Fabregat-Franco C; Persano M; Burgio V; Bergamo F; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Target Oncol; 2023 Jan; 18(1):139-145. PubMed ID: 36689074
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of PCSK9 and blood lipid in patients with sepsis].
Chen X; Huang X; Tian H; Kong G; Hu H; Lyu B; Liu X; Lu F; Shang Q; Hao D; Wang X; Wang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):614-619. PubMed ID: 35924517
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study.
Yuan ZB; Fang HB; Feng QK; Li T; Li J
World J Gastroenterol; 2022 Apr; 28(15):1574-1587. PubMed ID: 35582131
[TBL] [Abstract][Full Text] [Related]
39. A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.
Maßmann M; Treckmann J; Markus P; Schumacher B; Albers D; Ting S; Mende B; Roehrle J; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Schmid KW; Baba H; Siveke JT; Paul A; Schildhaus HU; Schuler M; Wiesweg M; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5085-5094. PubMed ID: 36334155
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
Lv M; Wang K; Zhang Z; Zhang Z; Wan J
Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
